Breast cancer: Overview & updates

Nurse Practitioner

Volumn 36, Issue 12, 2011, Pages 20-26

  Downs Holmes, Catherine ^a   Silverman, Paula ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Cleveland Clinic Taussig Cancer Institute   (United States)

Author keywords

Breast cancer; Evidence based breast cancer endocrine treatment; Metastatic breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; FEMALE; FOLLOW UP; HUMAN; MORTALITY; PATHOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOADJUVANT THERAPY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SURVIVAL RATE;

EID: 84858035853     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000407602.29522.d7     Document Type: Article

References (0)